TRELLIS-8 PERIPHERAL INFUSION SYSTEM— 510(k) K130904

Substantially Equivalent

Covidien

FDA 510(k) clearance K130904 for TRELLIS-8 PERIPHERAL INFUSION SYSTEM, Substantially Equivalent on 2013-10-25. Applicant: Covidien. Device class: 2.

Clearance details

Applicant
Covidien
Product code
Code QEY
Device class
Class 2
Regulation
21 CFR 870.5150
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Mansfield, MA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code QEY

view all

More clearances from Covidien

view all

Recalls naming K130904

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K130904.

Data sourced from openFDA. This site is unofficial and independent of the FDA.